XML 38 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Collaborations (Details) - NMP - License And Commercialization Agreement
$ in Millions
1 Months Ended 38 Months Ended
Aug. 31, 2013
USD ($)
item
Sep. 30, 2016
USD ($)
NMP License and Commercialization Agreement    
Deferred Revenue   $ 0.8
Milestone revenue recognized   $ 0.0
Period of time for termination notice to be given prior to the first commercial sale in Japan 90 days  
Period of time for termination notice to be given after the first commercial sale in Japan 6 months  
Period of time for termination notice to be given after Company receives regulatory approval in Japan but fails to launch the product 6 months  
Maximum    
NMP License and Commercialization Agreement    
Potential milestone payment $ 4.5  
Up-front Payment Arrangement    
NMP License and Commercialization Agreement    
Upfront payment received $ 1.0  
Achievement Of Regulatory Milestones    
NMP License and Commercialization Agreement    
Number of cancer indications requiring achievement of regulatory goals | item 5